Diabetes Reduces the Brain's Production of Natural Painkilling Opioid Peptides
Diabetes significantly reduced POMC gene expression in both the hypothalamus and pituitary of rats, and insulin treatment restored it, linking diabetic neuropathy to opioid peptide deficiency.
Quick Facts
What This Study Found
STZ-induced diabetes decreased POMC mRNA by significant amounts in the hypothalamic arcuate nucleus and anterior pituitary by 2-4 weeks, with insulin treatment (3 weeks) normalizing expression levels.
Key Numbers
How They Did This
Animal study in rats with STZ-induced diabetes. Three groups: 2-week diabetic, 4-week diabetic, and 4-week diabetic with 3 weeks insulin treatment. POMC mRNA measured by in situ hybridization in arcuate nucleus and anterior pituitary.
Why This Research Matters
Diabetic neuropathy causes significant pain and suffering. If diabetes suppresses the brain's natural opioid production, this provides a mechanism for diabetic pain syndromes and suggests opioid peptide supplementation could help.
The Bigger Picture
Diabetes doesn't just damage peripheral nerves — it disrupts central pain control by reducing opioid peptide production. This whole-system perspective on diabetic neuropathy could change how we approach pain management in diabetes.
What This Study Doesn't Tell Us
Rat diabetes model (STZ) may not perfectly replicate human type 1 or type 2 diabetes. POMC mRNA changes don't necessarily equate to proportional changes in active peptide levels. The functional pain consequences were not directly measured.
Questions This Raises
- ?Is POMC expression reduced in human diabetic patients?
- ?Could opioid peptide supplementation help manage diabetic neuropathy?
- ?Does the type of diabetes (1 vs 2) affect POMC expression differently?
Trust & Context
- Key Stat:
- Insulin restores opioids Insulin treatment normalized POMC expression that was suppressed by diabetes, suggesting proper glucose control protects the brain's natural pain relief system
- Evidence Grade:
- Preliminary animal evidence with clear molecular findings in a standard diabetes model, but functional pain consequences not assessed.
- Study Age:
- Published in 1999. The connection between diabetes, opioid peptides, and pain regulation continues to be studied.
- Original Title:
- STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.
- Published In:
- The American journal of physiology, 276(5), R1320-6 (1999)
- Authors:
- Kim, E M(3), Grace, M K(3), Welch, C C(3), Billington, C J, Levine, A S
- Database ID:
- RPEP-00531
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does diabetes affect your natural painkillers?
Yes. This study shows diabetes reduces production of POMC, the gene that makes beta-endorphin and other natural opioid painkillers. This could contribute to the pain sensitivity and neuropathy seen in diabetes.
Does insulin help protect the opioid system?
In this study, insulin treatment restored opioid peptide gene expression to near-normal levels. This suggests that good blood sugar control with insulin may help maintain the brain's natural pain relief system.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00531APA
Kim, E M; Grace, M K; Welch, C C; Billington, C J; Levine, A S. (1999). STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.. The American journal of physiology, 276(5), R1320-6. https://doi.org/10.1152/ajpregu.1999.276.5.R1320
MLA
Kim, E M, et al. "STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.." The American journal of physiology, 1999. https://doi.org/10.1152/ajpregu.1999.276.5.R1320
RethinkPeptides
RethinkPeptides Research Database. "STZ-induced diabetes decreases and insulin normalizes POMC m..." RPEP-00531. Retrieved from https://rethinkpeptides.com/research/kim-1999-stzinduced-diabetes-decreases-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.